47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
26.60.Z - Manufacture of irradiation equipment, electromedical and electrotherapeutic equipment
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
73.11.Z - Advertising agency activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,8 | 0,7 | 0,9 | 26,8 |
Gross profit (loss) | 0,8 | 0,7 | 0,9 | 17,2 |
EBITDA | 0,8 | 0,7 | 0,9 | 17,3 |
Short time liabilities | 1,9 | 3,6 | 3,6 | -0,6 |
Other operating costs | 0 | 0 | 0 | -12 |
Equity capital | 1,2 | 1 | 0,9 | -7,4 |
Operating profit (EBIT) | 0,8 | 0,7 | 0,9 | 17,3 |
Assets | 3,1 | 4,6 | 4,5 | -2,1 |
Net profit (loss) | 0,8 | 0,7 | 0,9 | 17,2 |
Cash | 1,1 | 1,1 | 0,9 | -15,4 |
Net income from sale | 16 | 18,5 | 21,6 | 16,4 |
Liabilities and provisions for liabilities | 1,9 | 3,6 | 3,6 | -0,6 |
Working assets | 3 | 4,5 | 4,4 | -2,1 |
Other income costs | 0 | 0,1 | 0 | -82,2 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 65 | 73,3 | 92,8 | 19,5 |
Equity capital to total assets | 38,4 | 21,9 | 20,7 | -1,2 |
Gross profit margin | 4,8 | 4 | 4 | 0 |
EBITDA Margin | 4,9 | 4 | 4 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 44 | 71 | 60 | -11 |
Current financial liquidity indicator | 1.5932708978652954 | 1.264217495918274 | 1.2450664043426514 | -0,1 |
Net dept to EBITDA | -1.4052611589431763 | -1.5195449590682983 | -1.0964215993881226 | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane